DBVT vs. TRVI
DBVT (DBV Technologies S.A.) and TRVI (Trevi Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, DBVT returned -22.05%/yr vs 56.45%/yr for TRVI. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
DBVT vs. TRVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DBVT achieves a -29.16% return, which is significantly lower than TRVI's 42.97% return.
DBVT
- 1D
- 0.59%
- 1M
- -14.16%
- 6M
- -37.10%
- YTD
- -29.16%
- 1Y
- 50.89%
- 3Y*
- -4.11%
- 5Y*
- -22.05%
- 10Y*
- -27.56%
- ALL TIME*
- -21.41%
TRVI
- 1D
- -1.92%
- 1M
- -0.17%
- 6M
- 63.32%
- YTD
- 42.97%
- 1Y
- 144.20%
- 3Y*
- 97.32%
- 5Y*
- 56.45%
- 10Y*
- —
- ALL TIME*
- 9.14%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $4.77M | $4.36M | $4.61M | |
| $29.66M | $45.48M | $35.03M |
DBVT vs. TRVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
DBVT DBV Technologies S.A. | -29.16% | 520.39% | -67.57% | -37.73% | -4.37% | -38.93% | -75.51% | 10.08% |
TRVI Trevi Therapeutics, Inc. | 42.97% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
Correlation
The correlation between DBVT and TRVI is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.08 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.10 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.12 |
Fundamentals
DBVT:
$324.86M
TRVI:
$2.54B
DBVT:
-$0.00
TRVI:
-$0.47
DBVT:
$0.00
TRVI:
$0.00
DBVT:
-$12.78M
TRVI:
-$31.00K
DBVT:
-$162.79M
TRVI:
-$49.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DBVT vs. TRVI — Risk / Return Rank
DBVT
TRVI
DBVT vs. TRVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for DBV Technologies S.A. (DBVT) and Trevi Therapeutics, Inc. (TRVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DBVT | TRVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.60 | ||
| Sortino ratioReturn per unit of downside risk | -1.04 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.35 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.14 | 4.92 | -3.78 |
| Martin ratioReturn relative to average drawdown | 2.55 | 11.54 | -8.99 |
Loading charts...
Drawdowns
DBVT vs. TRVI - Drawdown Comparison
The maximum DBVT drawdown since its inception was -99.52%, roughly equal to the maximum TRVI drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for DBVT and TRVI.
Loading charts...
Drawdown Indicators
| DBVT | TRVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -95.45% | -4.07% |
Max Drawdown (1Y)Largest decline over 1 year | -44.99% | -29.50% | -15.49% |
Max Drawdown (3Y)Largest decline over 3 years | -86.60% | -55.99% | -30.61% |
Max Drawdown (5Y)Largest decline over 5 years | -96.04% | -78.10% | -17.94% |
Max Drawdown (10Y)Largest decline over 10 years | -99.52% | — | — |
Current DrawdownCurrent decline from peak | -97.25% | -8.21% | -89.04% |
Average DrawdownAverage peak-to-trough decline | -70.61% | -60.44% | -10.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.01% | 12.55% | +7.46% |
Volatility
DBVT vs. TRVI - Volatility Comparison
The current volatility for DBV Technologies S.A. (DBVT) is 15.64%, while Trevi Therapeutics, Inc. (TRVI) has a volatility of 25.46%. This indicates that DBVT experiences smaller price fluctuations and is considered to be less risky than TRVI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DBVT | TRVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.64% | 25.46% | -9.82% |
Volatility (6M)Calculated over the trailing 6-month period | 40.03% | 42.50% | -2.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.11% | 63.56% | +11.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.71% | 88.79% | +3.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.66% | 98.96% | -13.30% |
Dividends
DBVT vs. TRVI - Dividend Comparison
Neither DBVT nor TRVI has paid dividends to shareholders.
Financials
DBVT vs. TRVI - Financials Comparison
This section allows you to compare key financial metrics between DBV Technologies S.A. and Trevi Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DBVT and TRVI have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TRVI has higher volatility (25.46%) compared to DBVT (15.64%). In terms of maximum drawdown, DBVT dropped -99.52% vs TRVI's -95.45%.
TRVI currently has the higher Sharpe Ratio (2.29 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DBVT and TRVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer